Cresco Labs (CRLBF) Asset Utilization Ratio (2021 - 2026)
Cresco Labs' (CRLBF) quarterly Asset Utilization Ratio came in at 0.54 in Q1 2026, up 3.14% YoY from 0.52 in Q1 2025, and up 1.13% on a QoQ basis from 0.53 in Q4 2025.
Cresco Labs (CRLBF) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 6 years of Asset Utilization Ratio data on file, last reported at 0.54 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 3.14% year-over-year to 0.54 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.54 (up 3.14% YoY) and the FY2025 annual result came in at 0.51, down 3.74% from the prior year.
- Asset Utilization Ratio rose to 0.54 in Q1 2026, from 0.53 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.56 in Q1 2024 to a low of 0.46 in Q1 2022.
- A 5-year average of 0.52 and a median of 0.52 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio advanced 15.04% — and 2025, when it dropped 8.13%.
- Tracing CRLBF's Asset Utilization Ratio over 5 years: stood at 0.5 in 2022, then increased by 10.8% to 0.56 in 2023, then decreased by 5.37% to 0.53 in 2024, then increased by 0.07% to 0.53 in 2025, then increased by 1.13% to 0.54 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.54 (Q1 2026), 0.53 (Q4 2025), and 0.51 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cresco Labs | 290.46 Mn | 226.34 Mn | 86.95 Mn | 0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.54 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | 0.55 |
| Mar 31, 2024 | 0.56 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.52 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.50 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 0.47 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.44 |